Capricor Therapeutics
CAPR
CAPR
31 hedge funds and large institutions have $9.94M invested in Capricor Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.62% less ownership
Funds ownership: 11.47% → 10.85% (-0.62%)
41% less capital invested
Capital invested by funds: $16.8M → $9.94M (-$6.81M)
Holders
31
Holding in Top 10
–
Calls
$1.31M
Puts
$1.02M
Top Buyers
| 1 | +$109K | |
| 2 | +$98.4K | |
| 3 | +$49.6K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$24.8K |
| 5 |
State Street
Boston,
Massachusetts
|
+$22K |
Top Sellers
| 1 | -$210K | |
| 2 | -$202K | |
| 3 | -$88.3K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$63.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$34.5K |